Intervention1: Resveratrol-Copper tablets: Patients will receive Resveratrol-Copper tablets (1 tablet 4 times per day) from the date of randomization to the day of discharge or death, whichever is ear
Sponsors
Tata Memorial Centre
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere
Phase 3
Randomized Controlled Trial Of Resveretrol-Copper Or Sodium-Copper-Chlorophyllin Vs Standard Treatment In Mild Covid-19 infection
Active, not recruitingCTRI/2020/05/025336
Target: 300Updated: 2021-11-24
Randomized Controlled Trial Of Resveretrol-Copper Or Sodium-Copper-Chlorophyllin Vs Standard Treatment In Mild Covid-19 infection with Cancer Patients.
Active, not recruitingCTRI/2020/07/026515
Target: 300Updated: 2021-11-24